Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient dataBruce Campbell, Edrich Rodrigues, Henry Ma et al.|The Lancet|2019Cited by 524
Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level dataBruce Campbell, Michael D. Hill, Hester F. Lingsma et al.|The Lancet Neurology|2018Cited by 392
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trialMagdy Selim, Heena Olalde, Lydia D. Foster et al.|The Lancet Neurology|2019Cited by 249
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic OriginPierre Amarenco, Philippe Desfontaines, Hans Denison et al.|Stroke|2020Cited by 100
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark Parsons, Vignan Yogendrakumar, Leonid Churilov et al.|The Lancet Neurology|2024Cited by 89